Delivery Order SPE2DB24D3013-SPE2DB25FFQFJ
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,156.56 and is scheduled for completion by October 9, 2025. The contract was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orgovyx 120 mg tablets (30-unit package) with a ceiling value of $1,385.52 and an ultimate completion date of October 6, 2025. This delivery order is a non-set-aside award utilizing firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This order, valued at $16,626.24 with a firm fixed price structure, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply contract. The order is scheduled for completion by October 2, 2025, and will be fulfilled from the company's Corporate Office facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,771.04 and an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- This delivery order, awarded on July 30, 2025, to AmerisourceBergen Drug Corp supplies 30 tablets of Orgovyx 120 mg under a firm fixed price contract valued at $2,771.04. The award is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is funded through the Defense agency's Medical Supply Chain and represents a child contract under a...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 30, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQFJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a ceiling value of $5,542.08 and an ultimate completion date of September 26, 2025. The award is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations by providing a specialized pharmaceutical product. Orgovyx, used in hormone-related medical treatment, will be supplied to fulfill military healthcare requirements. The contract demonstrates AmerisourceBergen's capability to meet federal procurement standards through competitive award processes, consistent with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to defense and civilian healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/5/25 |